Awarded Costs Constrained By Federal Rules And Regional Circuit Law
Client Alert | 1 min read | 02.09.06
In Summit Technology, Inc. v. Nidek Co., Ltd. (No. 05-1292; January 26, 2006), a Federal Circuit panel modifies the district court's award of costs, remanding the case to the lower court for entry of the modified award. At issue are the constraints of § 1920 of the Federal Rules of Civil Procedure dealing with taxation of specified costs, as applied under First Circuit law. The panel determines that video animations are not “exemplifications” as provided in 28 U.S.C. § 1920(4). Reviewing a variety of cases and Blacks Law Dictionary, which defines “exemplifications” as “[a]n official transcript of a public record, authenticated as true copy for use as evidence”, the panel determines that the First Circuit would adopt a narrow definition of “exemplifications” and refuse to allow recovery for video animations. The panel also reduces the lower court's award of photocopy and deposition costs as these portions of the award are not deemed properly supported by the evidentiary record.
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief
